COLXV is normally present in the stroma and its loss is evident preceding tumor progression, hence we tested the hypothesis that its interactions with cell-surface receptors such as α2β1 integrin, DDR1 and E-Cad, and subsequent signaling events might be critical to its function as a tumor suppressor. This evidence concerns the gene CD177 and neoplasm.